TASCINI, Carlo
 Distribuzione geografica
Continente #
NA - Nord America 12.676
AS - Asia 8.759
EU - Europa 4.758
SA - Sud America 1.942
Continente sconosciuto - Info sul continente non disponibili 1.433
AF - Africa 238
OC - Oceania 18
Totale 29.824
Nazione #
US - Stati Uniti d'America 12.159
SG - Singapore 4.575
IT - Italia 2.116
BR - Brasile 1.570
CN - Cina 1.310
HK - Hong Kong 1.004
VN - Vietnam 790
RU - Federazione Russa 478
FR - Francia 403
DE - Germania 327
IE - Irlanda 313
IN - India 229
CA - Canada 227
GB - Regno Unito 224
FI - Finlandia 176
BD - Bangladesh 173
UA - Ucraina 137
AR - Argentina 127
SE - Svezia 112
NL - Olanda 88
MX - Messico 87
TR - Turchia 86
KR - Corea 83
AT - Austria 82
IQ - Iraq 70
ZA - Sudafrica 70
ID - Indonesia 67
EC - Ecuador 65
JP - Giappone 57
CO - Colombia 55
ES - Italia 53
PL - Polonia 50
PK - Pakistan 45
JM - Giamaica 36
CR - Costa Rica 34
MA - Marocco 34
VE - Venezuela 33
BE - Belgio 27
PH - Filippine 26
UZ - Uzbekistan 25
CL - Cile 24
PE - Perù 23
SA - Arabia Saudita 23
LT - Lituania 21
PY - Paraguay 21
NI - Nicaragua 20
TG - Togo 19
CH - Svizzera 18
IL - Israele 18
JO - Giordania 18
TN - Tunisia 18
EG - Egitto 17
GT - Guatemala 17
KE - Kenya 17
HN - Honduras 16
NP - Nepal 15
BB - Barbados 14
DZ - Algeria 13
EE - Estonia 13
LB - Libano 13
AE - Emirati Arabi Uniti 12
TH - Thailandia 12
UY - Uruguay 12
AL - Albania 11
AZ - Azerbaigian 11
PR - Porto Rico 11
PT - Portogallo 11
TW - Taiwan 11
AU - Australia 10
CZ - Repubblica Ceca 10
MY - Malesia 10
RO - Romania 10
TT - Trinidad e Tobago 10
BO - Bolivia 9
DO - Repubblica Dominicana 9
GR - Grecia 9
HR - Croazia 9
KZ - Kazakistan 9
OM - Oman 9
SV - El Salvador 9
BG - Bulgaria 8
LV - Lettonia 8
PA - Panama 8
KG - Kirghizistan 7
RS - Serbia 7
BH - Bahrain 6
CI - Costa d'Avorio 6
CW - ???statistics.table.value.countryCode.CW??? 6
DK - Danimarca 6
ET - Etiopia 6
GE - Georgia 6
HU - Ungheria 6
AO - Angola 5
BY - Bielorussia 5
BZ - Belize 5
SY - Repubblica araba siriana 5
AM - Armenia 4
GP - Guadalupe 4
KH - Cambogia 4
KW - Kuwait 4
Totale 28.301
Città #
Singapore 1.654
San Jose 1.331
Ashburn 1.326
Hong Kong 983
Council Bluffs 732
Beijing 535
Chandler 465
Boardman 433
Redmond 384
Lauterbourg 313
Fairfield 307
Dublin 289
Woodbridge 283
Dallas 272
Ho Chi Minh City 268
Los Angeles 255
Wilmington 253
Princeton 249
Houston 238
Santa Clara 213
Udine 187
Milan 184
Ann Arbor 181
São Paulo 151
Redondo Beach 149
Seattle 146
Hanoi 141
Rome 140
Buffalo 137
New York 132
Cambridge 131
Helsinki 96
Phoenix 92
Mumbai 91
Hefei 85
North Bergen 79
Seoul 79
Dong Ket 76
Chicago 72
Frankfurt am Main 71
Nuremberg 69
Munich 68
Atlanta 67
The Dalles 64
Jacksonville 58
Montreal 57
Belluno 56
Naples 55
Tokyo 54
Toronto 54
Dearborn 52
Trieste 52
Denver 45
Norwalk 45
Orem 45
Rio de Janeiro 45
Johannesburg 42
Vienna 42
Brooklyn 41
Lappeenranta 41
Florence 40
Izmir 40
Brasília 37
San Diego 37
Bologna 35
Mexico City 35
Ogden 35
Warsaw 35
Belo Horizonte 34
Amsterdam 31
London 31
Washington 30
Des Moines 29
Guangzhou 29
Turin 29
San José 28
Da Nang 27
Haiphong 27
Newark 26
Philadelphia 26
San Francisco 25
Brussels 24
Baghdad 23
Stockholm 23
Turku 23
Chennai 22
Curitiba 22
Porto Alegre 22
Venice 22
Bogotá 21
Dhaka 21
Düsseldorf 21
Figino 21
Manchester 21
Palermo 21
Shanghai 21
Tashkent 21
Managua 20
Poplar 20
Charlotte 19
Totale 15.329
Nome #
Lessons learnt while designing and conducting a longitudinal study from the first Italian COVID-19 pandemic wave up to 3 years 305
Exploring ecological modelling to investigate factors governing the colonization success in nosocomial environment of Candida albicans and other pathogenic yeasts 253
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. 229
Gestione Diagnostico-Terapeutica del Paziente di Area Critica con Infezione Grave da Patogeni Batterici Multiresistenti 223
MR-proADM as prognostic factor of outcome in COVID-19 patients 214
A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality 197
Ceftolozane/tazobactam for the treatment of serious P. aeruginosa infections: a multicenter nationwide clinical experience 193
Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: An italian multidisciplinary consensus statement 191
Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use 187
An Italian consensus for invasive candidiasis management (ITALIC) 185
Ampicillin and Ceftobiprole Combination for the Treatment of Enterococcus faecalis Invasive Infections: “The Times They Are A-Changin” 182
Eravacycline: Data Based on Real Evidence 178
Variable incidence of candidemia in patients admitted to ICUs or medical wards of large tertiary-care Italian hospitals 178
Risk factors associated with the onset of daptomycin non-susceptibility in Staphylococcus aureus infections in critically ill patients 175
Population pharmacokinetics and pharmacodynamic target attainment of isavuconazole against aspergillus fumigatus and aspergillus flavus in adult patients with invasive fungal diseases: Should therapeutic drug monitoring for isavuconazole be considered as mandatory as for the other mold-active azoles? 174
Linezolid-resistant staphylococcal bacteraemia: A multicentre case-case-control study in Italy 165
MEDical wards Invasive Candidiasis ALgorithms (MEDICAL):Consensus proposal for management 164
Independent risk factors for mortality in critically ill patients with candidemia on Italian Internal Medicine Wards 162
Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care 162
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study 161
Lung Ultrasound Signs and Their Correlation With Clinical Symptoms in COVID-19 Pregnant Women: The “PINK-CO” Observational Study 152
Predictors of choice of initial antifungal treatment in intraabdominal candidiasis 151
Hyposmia and Dysgeusia in COVID-19: Indication to Swab Test and Clue of CNS Involvement 151
Combining Deep Phenotyping of Serum Proteomics and Clinical Data via Machine Learning for COVID-19 Biomarker Discovery 150
The Fall in Antibody Response to SARS-CoV-2: A Longitudinal Study of Asymptomatic to Critically Ill Patients up to 10 Months after Recovery 142
Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study 139
Effect of heparin treatment on pulmonary embolism and in-hospital death in unvaccinated COVID-19 patients without overt deep vein thrombosis 138
Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: Findings from a multicenter prospective observational study 137
Post–COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients 136
PK/PD Analysis of High-Dose Daptomycin Use in the Treatment of Bone and Joint Infections: Data from a Real-World Setting 136
The role of biofilm forming on mortality in patients with candidemia: a study derived from real world data 135
Ceftobiprole: drug evaluation and place in therapy 135
Reading and understanding an antibiogram 135
Mental health symptoms one year after acute COVID-19 infection: prevalence and risk factors 134
Risk factors for ventilator associated pneumonia due to carbapenemase-producing Klebsiella pneumoniae in mechanically ventilated patients with tracheal and rectal colonization 133
Low risk of reinfections and relation with serological response after recovery from the first wave of COVID-19 130
L'uso dei farmaci antimicrobici in terapia intensiva - Letteratura ragionata dell'antibiogramma 128
Detection of SARS-CoV-2 infection prevalence in 860 cancer patients with a combined screening procedure including triage, molecular nasopharyngeal swabs and rapid serological test. A report from the first epidemic wave 128
Vaccine Hesitancy among Italian Patients Recovered from COVID-19 Infection towards Influenza and Sars-Cov-2 Vaccination 127
KPC-producing Klebsiella pneumoniae gut decolonisation following ceftazidime/avibactam-based combination therapy: A retrospective observational study 126
Covid-19 and the role of smoking: the protocol of the multicentric prospective study COSMO-IT (COvid19 and SMOking in ITaly). 126
INFEZIONI da GRAM POSITIVI per QUADRO SINDROMICO Dal laboratorio alla clinica 126
A cluster of COVID-19 cases in a small Italian town: a successful example of contact tracing and swab collection 124
Local occurrence and fast spread of B.1.1.7 lineage: A glimpse into Friuli Venezia Giulia 124
One Word to Describe My Experience as a COVID-19 Survivor Six Months after Its Onset: Findings of a Qualitative Study 124
Risk factors and outcome of c. Difficile infection after hematopoietic stem cell transplantation 123
The impact of body composition on mortality of COVID-19 hospitalized patients: A prospective study on abdominal fat, obesity paradox and sarcopenia 122
Prognostic role of malnutrition diagnosed by bioelectrical impedance vector analysis in older adults hospitalized with covid-19 pneumonia: A prospective study 122
Cytokines from Bench to Bedside: A Retrospective Study Identifies a Definite Panel of Biomarkers to Early Assess the Risk of Negative Outcome in COVID-19 Patients 122
Safety and effcacy of subcutaneous administration of Beta-Lactams: a Systematic Review and Meta-analysis. (In: The 20th European Doctoral Conference in Nursing Science – EDCNS) 119
Clinical presentation and immunological features of Post-Malaria Neurologic Syndrome: a case report and review of literature 119
Candidemia in Patients with Body Temperature Below 37°C and Admitted to Internal Medicine Wards: Assessment of Risk Factors 118
Use of colistin in adult patients: A cross-sectional study 118
Echocardiographic Comparison of COVID-19 Patients with or without Prior Biochemical Evidence of Cardiac Injury after Recovery 118
Screening procedure for SARS-CoV-2 infection combining triage, nasopharyngeal swab and serological test in allogeneic stem cell transplantation recipients undergoing outpatient posttransplant follow-up 117
Higher levels of IL-6 early after tocilizumab distinguish survivors from non-survivors in COVID-19 pneumonia: a possible indication for deeper targeting IL-6 116
Acid-suppressant therapy does not influence absorption of azoles used in candidemia 116
A Randomized Controlled Trial to Examine the Efficacy and Safety of a New Super-Oxidized Solution for the Management of Wide Postsurgical Lesions of the Diabetic Foot 115
Persistence of fatigue in the absence of pathophysiological mechanisms in some patients more than 2 years after the original SARS-CoV-2 infection 113
Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients 113
A Global Declaration on Appropriate Use of Antimicrobial Agents across the Surgical Pathway 113
Validation of a Saliva-Based Test for the Molecular Diagnosis of SARS-CoV-2 Infection 113
Extracellular vesicle features are associated with COVID-19 severity 112
D-Dimer as Biomarker for Early Prediction of Clinical Outcomes in Patients With Severe Invasive Infections Due to Streptococcus Pneumoniae and Neisseria Meningitidis 111
A single-staggered dose of calcineurin inhibitor may be associated with neurotoxicity and nephrotoxicity immediately after liver transplantation 110
Antibody response and risk of reinfection over 2 years among the patients with first wave of COVID-19 108
A Novel Immunosuppressive Strategy Combined with Preemptive Antiviral Therapy Improves the Eighteen-Month Mortality in HCV Recipients Transplanted with Aged Livers 108
Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience 107
AmpC -lactamase-producing Enterobacterales: what a clinician should know 107
Mid-regional pro-adrenomedullin as a supplementary tool to clinical parameters in cases of suspicion of infection in the emergency department 107
A Comparative Evaluation of Aztreonam-Avibactam and Ceftazidime-Avibactam Plus Aztreonam for Infections Due to MBL-Producing Enterobacterales 106
L’interpretazione del fenotipo antibiotico come strumento per il clinico. 105
Cefditoren: a clinical overview 104
Enterobacterales multiresistenti - Dal laboratorio alla clinica 104
Ventilatory associated barotrauma in COVID-19 patients: A multicenter observational case control study (COVI-MIX-study) 103
2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HRS/LAHRS 103
A prediction rule for early recognition of patients with candidemia in Internal Medicine: results from an Italian, multicentric, case-control study 103
COVID-19-induced neuropsychiatric symptoms can persist long after acute infection: a 2-year prospective study of biobehavioral risk factors and psychometric outcomes 102
Post-COVID-19 Syndrome as Described by Patients: A Qualitative Study 102
Meropenem PK/PD Variability and Renal Function: “We Go Together” 101
Renal Function and Its Impact on the Concentration of Ceftazidime-Avibactam: A cross-sectional study 100
Antibody, cell-mediated response and infection susceptibility in allogeneic hematopoietic stem cell recipients after COVID-19 mRNA vaccination 99
Mono vs. combo regimens with novel beta-lactam/beta-lactamase inhibitor combinations for the treatment of infections due to carbapenemase-producing Enterobacterales: insights from the literature 99
European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) 99
Relationship between cytokine release and stress hyperglycemia in patients hospitalized with COVID-19 infection 98
A Rapid High-Performance Liquid Chromatography Method to Measure Linezolid and Daptomycin Concentrations in Human Plasma 98
A NEW IMMUNOSUPPRESSIVE STRATEGY COMBINED WITH EARLY ANTIVIRAL THERAPY IMPROVES SURVIVAL AND LEADS TO HCV ERADICATION AT THE SAME COST OF THE HBV PROPHYLAXIS 3 YEARS AFTER LIVER TRANSPLANTATION 98
Longest incubation period of Mycobacterium chimaera infection after cardiac surgery 98
Safety and Pharmacokinetic Profiles of Subcutaneous Administration of Beta-Lactams: A Systematic Review 97
Approach to patients with COVID-19 disease: The procedure in Udine 96
The Impact of Epidemiological Trends and Guideline Adherence on Candidemia-Associated Mortality: A 14-Year Study in Northeastern Italy 94
A microbiological and structural analysis of the interplay between sulbactam/durlobactam and imipenem against penicillin-binding proteins (PBPs) of Acinetobacter spp 94
Pragmatic overview on acute bacterial and fungal infections of the central nervous system: a holistic update from diagnosis to treatment 93
L'uso dei Farmaci Antifungini nel Paziente Critico. Le Infezioni Fungine nel Paziente Critico dal Laboratorio alla Clinica per Ottimizzare la Diagnosi e la Terapia 93
Accuracy of point-of-care ultrasound to identify the source of infection in septic patients: a prospective study-comment 93
Potential role of avibactam in restoring susceptibility in Escherichia coli with two copies of blaKPC-3 and PBP3 mutations 92
Barotrauma during Noninvasive Respiratory Support in COVID-19 Pneumonia Outside ICU: The Ancillary COVIMIX-2 Study 92
A Position Paper on IgM-Enriched Intravenous Immunoglobulin Adjunctive Therapy in Severe Acute Bacterial Infections: The TO-PIRO SCORE Proposal 92
Liposome composition of colistin for intravenous, oral, and cutaneous therapheutic use, and process for its preparation 92
A dangerous job 92
Totale 13.054
Categoria #
all - tutte 147.408
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 147.408


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.248 0 0 0 50 85 31 52 105 95 222 331 277
2022/20231.506 271 124 21 141 121 410 47 70 168 15 65 53
2023/2024922 102 46 60 52 98 108 41 147 59 83 37 89
2024/20255.961 143 364 215 250 136 263 403 309 837 519 966 1.556
2025/202612.309 831 1.277 1.238 1.433 1.728 968 1.447 472 632 975 872 436
2026/20274.315 411 748 1.143 2.013 0 0 0 0 0 0 0 0
Totale 29.824